855400-66-7

Usage

Uses

Used in Pharmaceutical Synthesis:
3-Bromo-5-methoxyphenol is used as a building block in the synthesis of pharmaceuticals for its ability to contribute to the development of new drugs. Its unique structure allows for the creation of diverse molecular architectures, which is essential in drug discovery.
Used in Agrochemical Production:
In the agrochemical industry, 3-Bromo-5-methoxyphenol is used as a precursor in the production of various agrochemicals, contributing to the development of effective and safe products for agricultural use.
Used in Chemical Research:
3-Bromo-5-methoxyphenol serves as a reagent in chemical research, aiding scientists in understanding and advancing the field of organic chemistry through its unique properties and reactivity.
Used in Fine Chemicals Synthesis:
As an intermediate, 3-Bromo-5-methoxyphenol is used in the synthesis of other fine chemicals, which are important in various industries, including fragrances, dyes, and specialty chemicals.
Used in Antimicrobial Compounds Development:
3-Bromo-5-methoxyphenol is used as a starting material for developing novel antimicrobial compounds due to its inherent antimicrobial properties, which can be harnessed to create new treatments and preventive measures against microbial infections.
Used in Antioxidant Compounds Development:
With its antioxidant properties, 3-Bromo-5-methoxyphenol is utilized in the development of new antioxidant compounds, which have potential applications in various industries, including pharmaceuticals, cosmetics, and food preservation.
Used in Materials Science:
3-Bromo-5-methoxyphenol's potential applications in materials science are being explored, where its unique structure and properties could contribute to the development of new materials with specific characteristics and functions.

InChI:InChI=1/C7H7BrO2/c1-10-7-3-5(8)2-6(9)4-7/h2-4,9H,1H3

Upstream product

• 16618-68-1 3-bromo-5-methoxyaminobenzene 
• 20469-65-2 1-bromo-3,5-dimethoxybenzene 

Downstream Products

• 106120-04-1 5-bromoresorcinol 
• 99853-30-2 (2-bromo-4-hydroxy-6-methoxy-phenyl)-glyoxylic acid ethyl ester 
• 20469-65-2 1-bromo-3,5-dimethoxybenzene 
• 1346245-39-3 C₁₄H₁₉BrO₄ 
• 1346245-42-8 C₁₁H₁₅BrO₄ 
• 1235566-57-0 C₁₀H₁₃BrO₂ 

Relevant academic research and scientific papers

SUBSTITUTED HYDROXYSTILBENE COMPOUNDS AND DERIVATIVES SYNTHESIS AND USES THEREOF

The present disclosure relates to substituted hydroxystilbene compounds and derivatives, specifically 2-substituted hydroxystilbene compounds and derivatives, the synthesis of such compounds and their use in therapy.

Total Synthesis of Citreochlorol Monochloro Analogues via a Catalytically Enantioselective Carbonyl Allylation

An efficient synthetic route to citreochlorol analogues, halogenated polyketide secondary metabolites, is described. The key features are Krische s enantioselective carbonyl allylation, IBr-promoted cyclization, and regioselective epoxide opening. The importance of the route lies in accessing a versatile epoxy ether that enables the formation of citreochlorol monochloro derivatives.

Total synthesis of decarboxyaltenusin

The total synthesis of decarboxyaltenusin (5'-methoxy-6-methyl-[1,1'-biphenyl]-3,3',4-triol), a toxin produced by various mold fungi, has been achieved in seven steps in a yield of 31% starting from 4-methylcatechol and 1-bromo-3,5-dimethoxybenzene, where

Palladium-Catalyzed Regioselective Synthesis of 1-Hydroxycarbazoles Under Aerobic Conditions

A palladium-catalyzed aerobic C?H amidation of N-Ts-2-amino-3′-hydroxylbiaryls has been developed to afford a diverse range of 1-hydroxycarbazoles with high regioselectivity and efficiency. This protocol benefits from operational simplicity, robustness, a

First total synthesis of medicinally important 3,4,7-trimethoxy-9,10-dihydrophenanthrene-1,5-diol

The first total synthesis was successfully achieved for biologically active 9,10-dihydrophenanthrene-1,5-diol. The key features of our synthetic approach are Perkin condensation, followed by bromination, palladium mediated intramolecular C-C bond coupling, and selective isopropyl ether cleavage. Synthesized compounds were purified and characterized by IR, 1HNMR, 13CNMR and HRMS/LC-MS.

Synthesis of Benzyl Amines via Copper-Catalyzed Enantioselective Aza-Friedel-Crafts Addition of Phenols to N -Sulfonyl Aldimines

A new copper-catalyzed enantioselective aza-Freidel-Crafts reaction between phenols and N-sulfonyl aldimines that provides chiral secondary benzylamines in good to excellent yields and excellent enantioselectivities (up to 99% ee) is disclosed. In particular, excellent scope with alkylimines was observed for the first time. The synthetic utility of the products was demonstrated in the first enantioselective synthesis of a dual orexin receptor antagonist, a compound that contains an amine-bearing stereocenter adjacent to a bis-ortho-functionalized arene.

Total synthesis of the resveratrol oligomers (±)-Ampelopsin B and (±)-σ-Viniferin

The total synthesis of the resveratrol dimers (±)-ampelopsin B and (±)-σ-viniferin is reported. Highlights of the approach include the use of cyclopropylmethyl groups to protect aromatic alcohols. This group allows an acid promoted three-step, one-pot dep

ALKYNYL DERIVATIVES USEFUL AS DPP-1 INHIBITORS

The present invention is directed to novel alkynyl derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by DPP-1.

NOVEL PHENYLPYRROLE DERIVATIVE

The present invention relates to a compound or a pharmacologically acceptable salt thereof having superior glucokinase activating activity, and is a compound represented by general formula (I), or pharmacologically acceptable salt thereof: [wherein, A represents, for example, an oxygen atom or sulfur atom, R1 represents, for example, a C1-C6 alkyl group, a C1-C6 alkoxy group or a C1-C6 halogenated alkyl group, A and R1 together with the carbon atom bonded thereto form a heterocyclic group that may be substituted with 1 to 3 group(s) independently selected from Substituent Group α, R2 represents a phenyl group that may be substituted with 1 to 5 group(s) independently selected from Substituent Group α or a heterocyclic group that may be substituted with 1 to 3 group(s) independently selected from Substituent Group α, R3 represents a hydroxy group or a C1-C6 alkoxy group, and Substituent Group α consists of, for example, a halogen atom, a C1-C6 alkyl group, a C1-C6 alkyl group substituted with 1 or 2 hydroxy group(s), a C1-C6 alkylsulfonyl group, and a group represented by the formula -V-NR5R6 (wherein, V represents a carbonyl group or a sulfonyl group, and R5 and R6 may be the same or different and respectively represent a hydrogen atom or a C1-C6 alkyl group, or R5 and R6 together with the nitrogen atom bonded thereto form a 4- to 6-membered saturated heterocycle that may be substituted with 1 or 2 group(s) independently selected from a C1-C6 alkyl group and a hydroxy group, and the 4- to 6-membered saturated heterocycle may further contain one oxygen atom or nitrogen atom)].

CARBOXAMIDE DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS

The invention relates to compounds of Formula (I) processes and intermediates for their preparation, their use as muscarinic antagonists and pharmaceutical composition containing them.